Viewing Study NCT05423769


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2026-01-05 @ 5:56 PM
Study NCT ID: NCT05423769
Status: COMPLETED
Last Update Posted: 2024-08-23
First Post: 2022-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt
Sponsor: Hikma Pharmaceuticals LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module